These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2164981)

  • 1. Glutamatergic neurotransmission in Alzheimer's disease.
    Cowburn RF; Hardy JA; Roberts PJ
    Biochem Soc Trans; 1990 Jun; 18(3):390-2. PubMed ID: 2164981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate transmission and toxicity in Alzheimer's disease.
    Greenamyre JT; Maragos WF; Albin RL; Penney JB; Young AB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):421-30. PubMed ID: 2900537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glutaminergic neurotransmission in Alzheimer's disease].
    Tooyama I; Yanagisawa D
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():214-8. PubMed ID: 22787784
    [No Abstract]   [Full Text] [Related]  

  • 4. Region-specific loss of glutamate innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Lofdahl E; O'Carroll AM; Wester P; Winblad B
    Neurosci Lett; 1987 Jan; 73(1):77-80. PubMed ID: 2882446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of excitotoxic mechanisms in Alzheimer's disease.
    May PC
    Neurobiol Aging; 1989; 10(5):606-8; discussion 618-20. PubMed ID: 2572984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons.
    Lewis DA; Glantz LA; Pierri JN; Sweet RA
    Ann N Y Acad Sci; 2003 Nov; 1003():102-12. PubMed ID: 14684438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal.
    Tsai GE; Ragan P; Chang R; Chen S; Linnoila VM; Coyle JT
    Am J Psychiatry; 1998 Jun; 155(6):726-32. PubMed ID: 9619143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.
    Lowe SL; Bowen DM; Francis PT; Neary D
    Neuroscience; 1990; 38(3):571-7. PubMed ID: 1980143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
    Palmer AM; Gershon S
    FASEB J; 1990 Jul; 4(10):2745-52. PubMed ID: 2165009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glutamate and Alzheimer's disease].
    Gazulla J; Cavero-Nagore M
    Rev Neurol; 2006 Apr 1-15; 42(7):427-32. PubMed ID: 16602060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamatergic Transmission: A Matter of Three.
    Martínez-Lozada Z; Ortega A
    Neural Plast; 2015; 2015():787396. PubMed ID: 26345375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic acid and Alzheimer's disease.
    Arias C; Becerra-García F; Tapia R
    Neurobiology (Bp); 1998; 6(1):33-43. PubMed ID: 9713830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate Receptors in Alzheimer's Disease: Mechanisms and Therapies.
    Anggono V; Tsai LH; Götz J
    Neural Plast; 2016; 2016():8256196. PubMed ID: 27293907
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's disease.
    Hascup KN; Hascup ER
    J Alzheimers Dis; 2015; 44(3):771-6. PubMed ID: 25374106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic systems in Alzheimer's disease.
    Francis PT
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S15-21. PubMed ID: 12973746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs].
    Hashimoto K; Iyo M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Feb; 22(1):3-13. PubMed ID: 11917507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate/aspartate-releasing neurons in Alzheimer's disease.
    Procter AW; Palmer AM; Stratmann GC; Bowen DM
    N Engl J Med; 1986 Jun; 314(26):1711-2. PubMed ID: 3713780
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutamatergic animal models of schizophrenia.
    Moghaddam B; Jackson ME
    Ann N Y Acad Sci; 2003 Nov; 1003():131-7. PubMed ID: 14684441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.